Surfactant protein-A levels in patients with acute respiratory distress syndrome

Indian Journal of Medical Research

Volumn 117, Issue MAR., 2003, Pages 129-133

  Balamugesh, T ^a   Kaur, S ^a   Majumdar, S ^a   Behera, D ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Acute lung injury; ARDS; Bronchial aspirates; Mechanical ventilation; PEEP; Pneumocytes; Pneumonia; Surfactant protein A

Indexed keywords

SURFACTANT PROTEIN A;

ACUTE RESPIRATORY TRACT DISEASE; ADOLESCENT; ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASPIRATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INDIA; INTENSIVE CARE UNIT; LUNG ALVEOLUS CELL; LUNG ALVEOLUS OXYGEN TENSION; LUNG FUNCTION; MALE; PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REHABILITATION CENTER; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY TRACT INFECTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VENTILATOR;

ACUTE DISEASE; ADOLESCENT; ADULT; BRONCHI; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PNEUMONIA; PROSPECTIVE STUDIES; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 84887110485     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Doyle RL, Szaflarski N, Modin GW, Wiener-Kronish JP, Matthay MA. Identification of patients with acute lung injury: Predictors of mortality. Am J Respir Crit Care Med 1995; 152 : 1818-24.
2. Honig EG, Ingram RH Jr. Acute respiratory distress syndrome. In: Fauci AS, Braunwald E, Isselbacher K Jr., Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, editors. Harrison's Principles of Internal Medicine, 14th ed. New York: McGraw-Hill; 1988 p. 1483-6.
3. Spragg G. Abnormalities of lung surfactant function in patients with acute lung injury. In: Warren MZ, Francous L, editors. Lung Biology in Health and Disease-ARDS. New York: Marcek Dekker; 1991; 50 : 381-95.
4. Strayer DS, Herting E, Sun B, Robertson B. Antibody to surfactant protein-A increases sensitivity of pulmonary surfactant to inactivation by fibrinogen in vivo. Am J Respir Crit Care Med 1996; 153 : 1116-22.
5. Gregory TJ, Longmore WJ, Moxley MA, Whitsett JA, Reed CR, Fowler AAI III, et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991; 88 : 1976-81.
6. Hallman M, Spragg R, Harrell JH, Moser KM, Gluck L. Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J Clin Invest 1982; 70 : 673-83.
7. Johansson J, Curstedt T, Robertson B. The proteins of the surfactant system. Eur Respir J 1994; 7 : 372-91.
8. Suzuki Y, Fujita Y, Kogishi K. Reconstitution of tubular myelin from synthetic lipids and proteins associated with pig pulmonary surfactant. Am Rev Respir Dis 1989; 140 : 75-81.
9. Higuchi R, Lewis J, Ikegami M. In vitro conversion of surfactant subtypes is altered in alveolar surfactant, isolated from injured lungs. Am Rev Respir Dis 1992; 145 : 1416-20.
10. Weaver TE, Whitsett JA. Function and regulation of expression of pulmonary surfactant-associated proteins. Biochem J 1991; 273 : 249-64.
11. Wrigth JR, Youmans DC. Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage. Am J Physiol 1993; 264 : L338-44.
12. Manz-Keinke H, Plattner H, Schlepper-Schafer J. Lung surfactant protein A(SP-A) enhances serum-independent phagocytosis of bacteria by alveolar macrophages. Eur J Cell Biol 1992; 57 : 95-100.
13. Veldhuizen RA, Marcou J, Yao LJ, McCaig L, Ito Y, Lewis JF. Alveolar surfactant aggregate conversion in ventilated normal and injured rabbits. Am J Physiol 1996; 270 : L152-8.
14. Woods E, Ohashi T, Polk D, Ikegami M, Ueda T, Jobe AH. Surfactant treatment and ventilation effects on surfactant SP-A, SP-B and SP-C mRNA levels in pre-term lamb lungs. Am J Physiol 1995; 269 : L209-14.
15. Wali A, Dhall K, Sanyal SN, Juneja R, Majumdar S. Immunoassay for the determination of surfactant apoprotein (SP-A) in human amniotic fluid: Comparison with other indices of assessing foetal lung maturity. Scand J Clin Lab Invest 1992; 52 : 355-60.
16. Sathyanarayana G. Surfactant protein-A and nitric oxide derivatives in lung lavage obtained from patients with idiopathic pulmonary fibrosis. M.D. thesis. PGIMER Chandigarh, 1999.
17. Veldhuizen RA, McCaig LA, Akino T, Lewis JF. Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995; 152 : 1867-71.
18. Pison U, Tam EK, Caughey GH, Hawgood S. Proteolytic inactivation of dog lung surfactant-associated proteins by neutrophil elastase. Biochim Biophys Acta 1989; 992 : 251-7.
19. Cockshutt AM, Weitz J, Possmayer F. Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro. Biochemistry 1990; 29 : 8424-9.
20. LeVine AM, Lotze A, Stanley S, Stroud C, O'Donnell R, Whitsett J, et al. Surfactant content in children with inflammatory lung disease. Crit Care Med 1996; 24 : 1062-7.
21. Wright JR. Immunomodulatory functions of surfactant. Physiol Rev 1997; 77 : 931-62.
22. Horowitz S, Dafni N, Shapiro DL, Holm BA, Notter RH, Quible DJ. Hyperoxic exposure alters gene expression in the lung. Induction of the tissue inhibitor of metalloproteinases mRNA and other mRNA. J Biol Chem 1989; 264 : 7092-5.
23. Nogee LM, Wispe JR. Effects of pulmonary oxygen injury on airway content of surfactant-associated protein A. Pediatr Res 1988; 24 : 568-73.